Refractory immune thrombocytopenic purpura: current strategies for investigation and management.
about
Immune thrombocytopeniaChildhood immune thrombocytopenia: Clinical presentation and managementThe ITP syndrome: pathogenic and clinical diversity.Intracranial hemorrhage (ICH) in children with immune thrombocytopenia (ITP): study of 40 cases.Effects of bisphosphonate administration on the bone mass in immune thrombocytopenic purpura patients under treatment with steroids.Autoimmune complications in chronic lymphocytic leukaemia (CLL).Improved regulatory T-cell activity in patients with chronic immune thrombocytopenia treated with thrombopoietic agents.Long-term outcomes of a 5-year follow up of patients with immune thrombocytopenic purpura after splenectomyCurrent treatment options for primary immune thrombocytopenia.ITP: a historical perspective.What's new in the management of chronic primary immune thrombocytopenia in adults and the use of thrombopoietin receptor agonists.Management of immune thrombocytopenic purpura in children: potential role of novel agents.Efficacy of rituximab in immune thrombocytopenic purpura: a retrospective survey.Crosstalk between Platelets and the Immune System: Old Systems with New DiscoveriesIdiopathic thrombocytopenic purpura during pregnancy.Adverse postoperative outcomes in surgical patients with immune thrombocytopenia.Does the site of platelet sequestration predict the response to splenectomy in adult patients with immune thrombocytopenic purpura?Autoimmune thrombocytopenia: a complication of fludarabine therapy in the treatment of Waldenstrom's macroglobulinemiaCD8+ T cells are predominantly protective and required for effective steroid therapy in murine models of immune thrombocytopenia.Immune Thrombocytopenia in Two Unrelated Fanconi Anemia Patients - A Mere Coincidence?Refractory immune thrombocytopenia. Successful treatment with repeated cyclosporine A: two case reports.Refractory Immune Thrombocytopenic Purpura and Cytomegalovirus Infection: A Call for a Change in the Current Guidelines.Chronic immune thrombocytopenia in a child responding only to thrombopoietin receptor agonist.A case of refractory immune thrombocytopenia in pregnancy managed with elthrombopagImmune Thrombocytopenia and Obesity: Predictive Relationship.Safety and efficacy of romiplostim in splenectomized and nonsplenectomized patients with primary immune thrombocytopenia.Therapeutic implications of disorders of cell death signalling: membranes, micro-environment, and eicosanoid and docosanoid metabolismTreatment of Children with Persistent and Chronic Idiopathic Thrombocytopenic Purpura: 4 Infusions of Rituximab and Three 4-Day Cycles of Dexamethasone.Immune thrombocytopenic pupura-induced reversible posterior leukoencephalopathy successfully treated by rituximab.Efficacy and tolerability of old and new drugs used in the treatment of immune thrombocytopenia: Results from a long-term observation in clinical practice.
P2860
Q26830918-B988B727-419D-43CC-8C30-897622723942Q27023294-F40558B8-FE26-4938-A191-054F33A9320BQ33384235-8072FCF6-DEF5-4872-A1FE-B13443340C05Q33386303-4F7F1D56-96A1-4268-8F4F-342C8D7FB3F8Q33387310-EBC3F1DD-EC32-4361-92D0-C74DB5C84C4DQ33390656-8B48384E-3881-401F-80E6-EBD1E0F57A45Q33391221-7E6524FB-2982-4470-83AC-200FEAEF8598Q33393057-1040040A-A667-4C60-A14B-8AEF64416CE5Q33394149-F9BC8C6F-64D0-4259-A5F7-F6F030E67369Q33394791-14ECFFAD-D92A-4516-A562-6AC02CA9FFB4Q33395345-9667CB8B-6377-4CDB-947C-A96B00B9E024Q33395863-E9D1F7D8-3F7B-4B83-874C-5434D4E96DEBQ33395961-DD113714-69C4-4332-92C6-23B3C2DC20C9Q33403517-D5A01E44-3CA4-4C04-B551-E82BE17624B0Q33405239-9C80C3A4-CC72-4C62-BA80-ACF85E14E37FQ33405515-8F0FB079-641C-49AF-BEA1-E55CC281C2CDQ33417946-813B8DE9-7D57-4876-A1DA-0FEA1FC8785CQ33420255-E4DC1942-0027-4E39-B330-7D4C73E4C9BBQ33423336-6929AFC5-0C8A-4273-B4C9-7059049AEA1DQ33423865-5FD5A9FE-4B6A-4071-AACB-1830B5217453Q33424554-2D49525D-0570-4B01-97EC-E4B92DC03653Q33428970-D89C5275-84EB-474D-BD1C-463218FA7BABQ33434365-B41AF23F-2A3E-48B8-8B44-4B73B74C7726Q33435225-3C6C4AEB-746C-43D0-8D1C-F54E507E517FQ33440332-7291358A-5FBD-4992-AEEA-4B06DB82C2FAQ33441008-541B0A53-093F-4A0D-90AF-511B34D53065Q37988008-E5065FE4-789D-48FD-B737-E72944E29230Q47367088-07A7AF32-C6ED-445D-9357-74DBD468E738Q53817399-A737EB9B-4770-419A-971F-7A0A1138516DQ55332132-C022BE84-D6BA-479C-97F6-16662B47156F
P2860
Refractory immune thrombocytopenic purpura: current strategies for investigation and management.
description
2008 nî lūn-bûn
@nan
2008 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
name
Refractory immune thrombocytop ...... investigation and management.
@ast
Refractory immune thrombocytop ...... investigation and management.
@en
type
label
Refractory immune thrombocytop ...... investigation and management.
@ast
Refractory immune thrombocytop ...... investigation and management.
@en
prefLabel
Refractory immune thrombocytop ...... investigation and management.
@ast
Refractory immune thrombocytop ...... investigation and management.
@en
P2860
P1476
Refractory immune thrombocytop ...... investigation and management.
@en
P2860
P356
10.1111/J.1365-2141.2008.07275.X
P407
P577
2008-10-01T00:00:00Z